-
1Academic Journal
Authors: K. A. Turupaev, A. V. Klimov, O. A. Khalmurzaev, G. A. Arakelyan, D. D. Ladyko, S. D. Bezhanova, V. O. Vorob’eva, A. V. Smirnova, V. B. Matveev, К. А. Турупаев, А. В. Климов, О. А. Халмурзаев, Г. А. Аракелян, Д. Д. Ладыко, С. Д. Бежанова, В. О. Воробьева, А. В. Смирнова, В. Б. Матвеев
Source: Cancer Urology; Том 19, № 4 (2023); 119-124 ; Онкоурология; Том 19, № 4 (2023); 119-124 ; 1996-1812 ; 1726-9776
Subject Terms: светлоклеточный почечно-клеточный рак, organ-preserving surgical treatment, tumor thrombus, synchronous bilateral kidney cancer, papillary renal cell carcinoma, clear-cell renal cell carcinoma, органосохраняющее хирургическое лечение, опухолевый венозный тромбоз, синхронный двусторонний рак почек, папиллярный почечно-клеточный рак
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1688/1499; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1323; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1324; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1325; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1326; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1327; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1328; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1329; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1688/1330; Globocan (IARC) 2020. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/29-Kidney-fact-sheet.pdf.; Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 239 с.; Zhang C., Li X., Hao H. et al. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012; 110(11 Pt B):E481–5. DOI:10.1111/j.1464-410X.2012.11173.x; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543–52. DOI:10.1016/j.eururo.2010.12.013; Scosyrev E., Messing E.M., Sylvester R. et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372–7. DOI:10.1016/j.eururo.2013.06.044; Fergany A.F., Hafez K.S., Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163(2):442–5.; Patel S.H., Uzzo R.G., Larcher A. et al. Oncologic and functional outcomes of radical and partial nephrectomy in pt3a pathologically upstaged renal cell carcinoma: a multi-institutional analysis. Clin Ge-nitourin Cancer 2020;18(6):e723–9. DOI:10.1016/j.clgc.2020.05.002; Kolla S.B., Ercole C., Spiess P.E. et al. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein. BJU Int 2010;106(10):1494–8. DOI:10.1111/j.1464-410X.2010.09293.x; Yim K., Aron M., Rha K.H. et al. Outcomes of robot-assisted partial nephrectomy for clinical T3a renal masses: a multicenter analysis. Eur Urol Focus 2021;7(5):1107–14. DOI:10.1016/j.euf.2020.10.011; Woldu S.L., Barlow L.J., Patel T. et al. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein. Urology 2010;76(3):639–42. DOI:10.1016/j.urology.2009.10.073; Marra G., Gontero P., Brattoli M. et al. Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. Urol Oncol 2018;36(7):339.e1–8. DOI:10.1016/j.urolonc.2018.04.007; Morgan T.N., Dai J.C., Kusin S. et al. Clinical outcomes of robotic assisted partial nephrectomy for pathologic T3a renal masses with venous tumor thrombus. Urology 2022;159:120–6. DOI:10.1016/j.urology.2021.06.054; Zisman A., Pantuck A.J., Wieder J. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002;20(23):4559–66. DOI:10.1200/JCO.2002.05.111; Leibovich B.C., Blute M.L., Cheville J.C. et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97(7):1663–71. DOI:10.1002/cncr.11234; Eisen T., Frangou E., Oza B. et al. Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: results from the SORCE randomized phase III intergroup trial. J Clin Oncol 2020;38:4064–75. DOI:10.1200/JCO.20.01800; Gross-Goupil M., Kwon T., Eto M. et al. Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial. Ann Oncol 2018;29(12):2371–8. DOI:10.1093/annonc/mdy454; Haas N.B., Manola J., Uzzo R.G. et al. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet 2016;387(10032):2008–16. DOI:10.1016/S0140-6736(16)00559-6; Motzer R.J., Haas N.B., Donskov F. et al. Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma. J Clin Oncol 2017;35(35):3916–23. DOI:10.1200/JCO.2017.73.5324; Staehler M., Motzer R.J., George D.J. et al. Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial. Ann Oncol 2018;29(10):2098–104. DOI:10.1093/annonc/mdy329; Powles T., Tomczak P., Park S.H. et al. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2022;23(9):1133–44. DOI:10.1016/S1470-2045(22)00487-9; https://oncourology.abvpress.ru/oncur/article/view/1688
-
2Academic Journal
Authors: GENNADY BRATSLAVSKY, RONALD BORIS
Source: Malignant tumours; Том 1, № 1 (2011); 11-20 ; Злокачественные опухоли; Том 1, № 1 (2011); 11-20 ; 2587-6813 ; 2224-5057
Subject Terms: рецидив почечно-клеточного рака, органосохраняющее хирургическое лечение, роботизированная техника, аблация образований в почке
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/140/145; Jemal, A., Siegal, R., Ward E.: Cancer Statistics. A Cancer Journal for Clinicians, caac.20006v2, 5-27-2009; Chow, W. H., Devesa, S. S., Warren, J. L., Fraumeni, J. F., Jr.: Rising incidence of renal cell cancer in the United States. JAMA, 281: 1628, 1999; Hollingsworth, J. M., Miller, D. C., Daignault, S., Hollenbeck, B. K.: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98: 1331, 2006 4. Lopez-Beltran, A., Carrasco, J. C., Cheng, L., Scarpelli, M., Kirkali, Z., Montironi, R.: 2009 update on the classification of renal epithelial tumors in adults. Int J Urol, 16: 432, 2009; Linehan, W. M.: Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol, 27: 3731, 2009; Boris, R., Proano, M., Linehan, W. M., Pinto, P. A., Bratslavsky, G.: Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol, 182: 1280, 2009; Linehan, W. M., Vasselli, J., Srinivasan, R., Walther, M. M., Merino, M., Choyke, P. et al.: Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res, 10: 6282S, 2004; Rosner, B., Polk, B. F.: The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis, 32: 451, 1979; Feldman, D. R., Motzer, R. J.: Novel targets and therapies for metastatic renal cell carcinoma. Oncology (Williston Park), 20: 1745, 2006; Kruck, S., Merseburger, A. S., Gakis, G., Kramer, M. W., Stenzl, A., Kuczyk, M. A.: An update on the medical therapy of advanced metastatic renal cell carcinoma. Scand J Urol Nephrol, 42: 501, 2008; Rini, B. I., Bukowski, R. M.: Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress? Oncology (Williston Park), 22: 388, 2008; Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., Hsu, C. Y.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 351: 1296, 2004; Huang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V. et al.: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol, 7: 735, 2006 14. Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L., Russo, P.: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is; there a difference in mortality and cardiovascular outcomes? J Urol, 181: 55, 2009; Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C. et al.: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol, 179: 468, 2008; Weiner, D. E., Tabatabai, S., Tighiouart, H., Elsayed, E., Bansal, N., Griffith, J. et al.: Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis, 48: 392, 2006 17. Koenig, P., Gill, I.S., Kamoi K., Aron, M., Haber, G., Singh, A.B., Weight, CJ, Desai, MM, Kaouk, JH, Goldfarb, DA, Poggio, E.D.: Kidney cancer and the risk for chronic kidney disease: matched-paired comparison with living donors. The Journal of Urology, 179: 170, April 2008; McKiernan, J., Simmons, R., Katz, J., Russo, P.: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology, 59: 816, 2002; System, U. S. R. D.: Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), and US Department of Health and Human Services (DHHS). 2007; Foley, R. N., Parfrey, P. S., Sarnak, M. J.: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 32: S112, 1998; Rocco, M., Frankenfield, DL, Hopson SK, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann. Intern. Med, 145: 512, 2006; Neil, N., Guest, S., Wong, L., Inglese, G., Bhattacharyya, S. K., Gehr, T. et al.: The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther, 31: 880, 2009; Kasiske, B. L., Cangro, C. B., Hariharan, S., Hricik, D. E., Kerman, R. H., Roth, D. et al.: The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant, 1 Suppl 2: 3, 2001; Lin, S. J., et al.: The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin. Transplant, 20: 245, 2006; Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H. et al.: Guideline for management of the clinical T1 renal mass. J Urol, 182: 1271, 2009; Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., Zincke, H.: Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol, 171: 1066, 2004; Touijer, K., Jacqmin, D., Kavoussi, L. R., Montorsi, F., Patard, J. J., Rogers, C. G. et al.: The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol, 57: 214, 2010; Gupta, G. N., Peterson, J., Thakore, K. N., Pinto, P. A., Linehan, W. M., Bratslavsky, G.: Oncological Outcomes; of Partial Nephrectomy for Multifocal Renal Cell Carcinoma Greater Than 4 cm. J Urol, 2010; Dash, A., Vickers, A. J., Schachter, L. R., Bach, A. M., Snyder, M. E., Russo, P.: Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int, 97: 939, 2006; Breau, R. H., Crispen, P. L., Jimenez, R. E., Lohse, C. M., Blute, M. L., Leibovich, B. C.: Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol, 183: 903, 2010; Woldu, S. L., Barlow, L. J., Patel, T., Hruby, G. W., Benson, M. C., McKiernan, J. M.: Single Institutional Experience with Nephron-sparing Surgery for Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined to the Renal Vein. Urology, 2010; Kolla, S. B., Ercole, C., Spiess, P. E., Pow-Sang, J. M., Sexton, W. J.: Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein. BJU Int, 2010; Kaul, S., Laungani, R., Sarle, R., Stricker, H., Peabody, J., Littleton, R. et al.: da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol, 51: 186, 2007; Ho, H., Schwentner, C., Neururer, R., Steiner, H., Bartsch, G., Peschel, R.: Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int, 103: 663, 2009; Gettman, M. T., Blute, M. L., Chow, G. K., Neururer, R., Bartsch, G., Peschel, R.: Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology, 64: 914, 2004 36. Caruso, R. P., Phillips, C. K., Kau, E., Taneja, S. S., Stifelman, M. D.: Robot assisted laparoscopic partial nephrectomy: initial experience. J Urol, 176: 36, 2006; Phillips, C. K., Taneja, S. S., Stifelman, M. D.: Robotassisted laparoscopic partial nephrectomy: the NYU technique. J Endourol, 19: 441, 2005; Michli, E. E., Parra, R. O.: Robotic-assisted laparoscopic partial nephrectomy: initial clinical experience. Urology, 73: 302, 2009; Deane, L. A., Lee, H. J., Box, G. N., Melamud, O., Yee, D. S., Abraham, J. B. et al.: Robotic versus standard laparoscopic partial/wedge nephrectomy: a comparison of intraoperative and perioperative results from a single institution. J Endourol, 22: 947, 2008; Rogers, C. G., Metwalli, A., Blatt, A. M., Bratslavsky, G., Menon, M., Linehan, W. M. et al.: Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol, 180: 2353, 2008; Rogers, C. G., Singh, A., Blatt, A. M., Linehan, W. M., Pinto, P. A.: Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol, 53: 514, 2008 42. Gill, I. S., Kavoussi, L. R., Lane, B. R., Blute, M. L., Babineau, D., Colombo, J. R., Jr. et al.: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol, 178: 41, 2007; Aron, M., Koenig, P., Kaouk, J. H., Nguyen, M. M., Desai, M. M., Gill, I. S.: Robotic and laparoscopic partial nephrectomy: a matched-pair comparison from a highvolume centre. BJU Int, 102: 86, 2008; Wang, A. J., Bhayani, S. B.: Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. Urology, 73: 306, 2009; Kutikov, A., Uzzo, R. G.: The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol, 182: 844, 2009; Boris, R. S., Sanford, T., Pinto, P.A, Linehan M.L., Bratslavsky G.: Off-clamp robot assisted partial nephrectomy for multifocal renal masses in the hereditary renal popula-tion. Journal of Urology, 183: e370, April 2010; Chung, P. H., Gupta G., Boris R.S.,Linehan W.M., Pinto P.A., Bratslavsky G.: Robot assisted laparoscopic partial nephrectomy for tumors greater than 4cm: Feasibility and early functional outcomes. Journal of Urology, 183: e355, April 2010; White, W. M., Haber, G. P., Goel, R. K., Crouzet, S., Stein, R. J., Kaouk, J. H.: Single-port urological surgery: single-center experience with the first 100 cases. Urology, 74: 801, 2009; Haber, G. P., Crouzet, S., Kamoi, K., Berger, A., Aron, M., Goel, R. et al.: Robotic NOTES (Natural Orifice Translumenal Endoscopic Surgery) in reconstructive urology: initial laboratory experience. Urology, 71: 996, 2008; Lee, B. R., Wolf, J. S., Jr.: Natural orifice transluminal endoscopic surgery (NOTES) partial nephrectomy. B. R. Lee, U. Boylu, M. Oommen, G. Fifer, R. Thomas and V. Joshi. J Urol, 183: 1731, 2010; Carraway, W. A., Raman, J. D., Cadeddu, J. A.: Current status of renal radiofrequency ablation. Curr Opin Urol, 19: 143, 2009; Pasticier, G., Timsit, M. O., Badet, L., De La Torre Abril, L., Halila, M., Fassi Fehri, H. et al.: Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol, 49: 485, 2006; Committee., A. P. G.: Chapter 1: Management of the clinical stage 1 renal mass: diagnosis and treatment recommendations. AUA guideline for management of the clinical stage 1 renal mass: 1, 2009; Zagoria, R. J., Hawkins, A. D., Clark, P. E., Hall, M. C., Matlaga, B. R., Dyer, R. B. et al.: Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol, 183: 201, 2004; Raman, J. D., Raj, G. V., Lucas, S. M., Williams, S. K., Lauer, E. M., Ahrar, K. et al.: Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int, 105: 496, 2010; Park, S., Anderson, J. K., Matsumoto, E. D., Lotan, Y., Josephs, S., Cadeddu, J. A.: Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol, 20: 569, 2006; McDougal, W. S., Gervais, D. A., McGovern, F. J., Mueller, P. R.: Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol, 174: 61, 2005; Levinson, A. W., Su, L. M., Agarwal, D., Sroka, M., Jarrett, T. W., Kavoussi, L. R. et al.: Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol, 180: 499, 2008; Gervais, D. A., McGovern, F. J., Arellano, R. S., McDougal, W. S., Mueller, P. R.: Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology, 226: 417, 2003; Malcolm, J. B., Berry, T. T., Williams, M. B., Logan, J. E., Given, R. W., Lance, R. S. et al.: Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol, 23: 907, 2009; Weld, K. J., Figenshau, R. S., Venkatesh, R., Bhayani, S. B., Ames, C. D., Clayman, R. V. et al.: Laparoscopic cryoablation for small renal masses: three-year follow-up. Urol; ogy, 69: 448, 2007; Lawatsch, E. J., Langenstroer, P., Byrd, G. F., See, W. A., Quiroz, F. A., Begun, F. P.: Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. J Urol, 175: 1225, 2006; Gill, I. S., Remer, E. M., Hasan, W. A., Strzempkowski, B., Spaliviero, M., Steinberg, A. P. et al.: Renal cryoablation: outcome at 3 years. J Urol, 173: 1903, 2005; Aron, M., Kamoi, K., Remer, E., Berger, A., Desai, M., Gill, I.: Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol, 183: 889, 2010; Stone, M. J., Venkatesan, A. M., Locklin, J., Pinto, P., Linehan, M., Wood, B. J.: Radiofrequency ablation of renal tumors. Tech Vasc Interv Radiol, 10: 132, 2007; Grimaldi, G., Reuter, V., Russo, P.: Bilateral non-familial renal cell carcinoma. Ann Surg Oncol, 5: 548, 1998; Klatte, T., Wunderlich, H., Patard, J. J., Kleid, M. D., Lam, J. S., Junker, K. et al.: Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int, 100: 21, 2007; Siemer, S., Uder, M., Zell, A., Ponicke, C., Humke, U., Ziegler, M. et al.: [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients]. Urologe A, 40: 114, 2001; Zincke, H., Swanson, S. K.: Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival. J Urol, 128: 913, 1982; Blute, M. L., Itano, N. B., Cheville, J. C., Weaver, A. L., Lohse, C. M., Zincke, H.: The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol, 169: 1276, 2003; Boorjian, S. A., Uzzo, R. G.: The evolving management of small renal masses. Curr Oncol Rep, 11: 211, 2009; Wunderlich, H. e. a.: Multifocality in renal cell carcinoma: A bilateral event? Urol. Int., 63: 160, 1999; Kowalczyk, K. J., Hooper, H. B., Linehan, W. M., Pinto, P. A., Wood, B. J., Bratslavsky, G.: Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol, 182: 2158, 2009; Hwang, J. J., Walther, M. M., Pautler, S. E., Coleman, J. A., Hvizda, J., Peterson, J. et al.: Radio frequency ablation of small renal tumors:: intermediate results. J Urol, 171: 1814, 2004; Walther, M. C., Shawker, T. H., Libutti, S. K., Lubensky, I., Choyke, P. L., Venzon, D. et al.: A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol, 163: 1424, 2000; Johnson, A., Sudarshan, S., Liu, J., Linehan, W. M., Pinto, P. A., Bratslavsky, G.: Feasibility and outcomes of repeat partial nephrectomy. J Urol, 180: 89, 2008; Ghavamian, R., Cheville, J. C., Lohse, C. M., Weaver, A. L., Zincke, H., Blute, M. L.: Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol, 168: 454, 2002; Saranchuk, J. W., Touijer, A. K., Hakimian, P., Snyder, M. E., Russo, P.: Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int, 94: 1323, 2004; Thompson, R. H., Leibovich, B. C., Lohse, C. M., Zincke, H., Blute, M. L.: Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol, 174: 855, 2005; Magera, J. S., Jr., Frank, I., Lohse, C. M., Leibovich, B. C., Cheville, J. C., Blute, M. L.: Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol, 179: 853, 2008; Stephenson, A. J., Hakimi, A. A., Snyder, M. E., Russo, P.: Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol, 171: 130, 2004; Herring, J. C., Enquist, E. G., Chernoff, A., Linehan, W. M., Choyke, P. L., Walther, M. M.: Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol, 165: 777, 2001; Bratslavsky, G., Liu, J. J., Johnson, A. D., Sudarshan, S., Choyke, P. L., Linehan, W. M. et al.: Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol, 179: 67, 2008; Nguyen, C. T., Lane, B. R., Kaouk, J. H., Hegarty, N., Gill, I. S., Novick, A. C. et al.: Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J Urol, 180: 104, 2008; Rogers, C. G., Menon, M, Weise, E., Gettman, M., Frank, I.,Shepard, D., et al.: Robotic partial nephrectomy: a multi-institutional analysis. Journal of Robotic Surgery, 2: 141, 2008; Benway, B. M., Wang, A. J., Cabello, J. M., Bhayani, S. B.: Robotic partial nephrectomy with sliding-clip renorrhaphy: technique and outcomes. Eur Urol, 55: 592, 2009 87. Liu, N. W., Khurana, K., Sudarshan, S., Pinto, P. A., Linehan, W. M., Bratslavsky, G.: Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol, 183: 1719, 2010; https://www.malignanttumors.org/jour/article/view/140
-
3Academic Journal
Authors: Серикова, С., Корочанская, Н., Дурлештер, В.
Subject Terms: ОРГАНОСОХРАНЯЮЩЕЕ ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ, ГАСТРОПЛАСТИКА, ЯЗВА ЖЕЛУДКА
File Description: text/html
-
4Academic Journal
-
5Academic Journal
Source: Экспериментальная и клиническая гастроэнтерология.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, ОРГАНОСОХРАНЯЮЩЕЕ ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ, ГАСТРОПЛАСТИКА, ЯЗВА ЖЕЛУДКА, 3. Good health
File Description: text/html
-
6Academic Journal
Source: Врач
Subject Terms: oncology, breast cancer, organ-sparing surgical treatment, Postoperative radiotherapy, Elderly patients with breast cancer, онкология, рак молочной железы, органосохраняющее хирургическое лечение, послеоперационная лучевая терапия, больные раком молочной железы пожилого возраста
Availability: https://repository.rudn.ru/records/article/record/101432/
